ARCH Venture Partners X, LLC - Insider Trading & Ownership

Entity
Company
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Partners X, LLC is at least $522M dollars as of February 20, 2024. ARCH Venture Partners X, LLC is the 10%+ Owner of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $383M. ARCH Venture Partners X, LLC is the 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $96.6M. ARCH Venture Partners X, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $25.1M. ARCH Venture Partners X, LLC is the 10%+ Owner of Erasca, Inc. and owns shares of Erasca, Inc. (ERAS) stock worth about $17.6M.
All Insider Reports
All Insider Reports

Ownership of ARCH Venture Partners X, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NMRA Neumora Therapeutics, Inc. 10%+ Owner $383M Dec 8, 2023
PRME Prime Medicine, Inc. 10%+ Owner $96.6M +$20M +26.1% Feb 15, 2024
VERV Verve Therapeutics, Inc. 10%+ Owner $25.1M Jun 21, 2021
ERAS Erasca, Inc. 10%+ Owner $17.6M Jul 20, 2021

Insider Transactions Reported by ARCH Venture Partners X, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.